151 related articles for article (PubMed ID: 8809644)
21. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
[TBL] [Abstract][Full Text] [Related]
22. Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy.
Suemaru K; Kawasaki H; Yasuhara K; Yao K; Furuno K; Kawakami Y; Araki H; Gomita Y; Oka E
Acta Med Okayama; 1998 Jun; 52(3):139-42. PubMed ID: 9661740
[TBL] [Abstract][Full Text] [Related]
23. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
24. [Optimisation of epilepsy monotherapy (clinico-pharmacological study)].
Gromov SA; Khorshev SK
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(7):31-5. PubMed ID: 9511212
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
Battino D; Estienne M; Avanzini G
Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
Jankovic SM; Jovanovic D; Milovanovic JR
Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
[TBL] [Abstract][Full Text] [Related]
27. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
Stephen LJ
Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
[TBL] [Abstract][Full Text] [Related]
28. Effect of xanthotoxin (8-methoxypsoralen) on the anticonvulsant activity of classical antiepileptic drugs against maximal electroshock-induced seizures in mice.
Zagaja M; Pyrka D; Skalicka-Wozniak K; Glowniak K; Florek-Luszczki M; Glensk M; Luszczki JJ
Fitoterapia; 2015 Sep; 105():1-6. PubMed ID: 26026802
[TBL] [Abstract][Full Text] [Related]
29. Rational use of antiepileptic drug levels.
Theodore WH
Pharmacol Ther; 1992; 54(3):297-305. PubMed ID: 1465479
[TBL] [Abstract][Full Text] [Related]
30. Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
Wietholtz H; Zysset T; Kreiten K; Kohl D; Büchsel R; Matern S
Eur J Clin Pharmacol; 1989; 36(4):401-6. PubMed ID: 2500346
[TBL] [Abstract][Full Text] [Related]
31. Detection of a drug-drug interaction on population-based phenobarbitone clearance using nonlinear mixed-effects modeling.
Yukawa E; To H; Ohdo S; Higuchi S; Aoyama T
Eur J Clin Pharmacol; 1998 Mar; 54(1):69-74. PubMed ID: 9591934
[TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.
Battino D; Estienne M; Avanzini G
Clin Pharmacokinet; 1995 Oct; 29(4):257-86. PubMed ID: 8549027
[TBL] [Abstract][Full Text] [Related]
33. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
[TBL] [Abstract][Full Text] [Related]
34. Mexiletine and its Interactions with Classical Antiepileptic Drugs: An Isobolographic Analysis.
Borowicz-Reutt KK; Banach M; Piskorska B
Neurochem Res; 2016 May; 41(5):1185-91. PubMed ID: 26738990
[TBL] [Abstract][Full Text] [Related]
35. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
[TBL] [Abstract][Full Text] [Related]
36. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K
J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic interactions of progabide with other antiepileptic drugs.
Bianchetti G; Padovani P; Thénot JP; Thiercelin JF; Morselli PL
Epilepsia; 1987; 28(1):68-73. PubMed ID: 3098557
[TBL] [Abstract][Full Text] [Related]
38. Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.
Eadie MJ
Clin Pharmacokinet; 1991 Jul; 21(1):27-41. PubMed ID: 1914340
[TBL] [Abstract][Full Text] [Related]
39. Detection of carbamazepine drug interaction by multiple peak approach screening using routine clinical pharmacokinetic data.
Yukawa E; Aoyama T
J Clin Pharmacol; 1996 Aug; 36(8):752-9. PubMed ID: 8877681
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of valproic acid in adult Chinese epileptic patients and its application in an individualized dosage regimen.
Lin WW; Jiao Z; Wang CL; Wang HY; Ma CL; Huang PF; Guo XZ; Liu YW
Ther Drug Monit; 2015 Feb; 37(1):76-83. PubMed ID: 24831653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
